Dr Reddy’s Receives Tentative USFDA Approval for Twice-Yearly HIV Prevention Shot
Dr Reddy’s Laboratories said it received tentative USFDA approval for its twice-yearly injectable lenacapavir.
Related stories
US Tribunal Bars Papaya From Transferring Assets Abroad
A US tribunal barred Papaya from transferring assets abroad in litigation involving a Firy subsidiary.
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
US Court Restricts Papaya Asset Transfers in Dispute With Skillz Subsidiary
A US court restricted Papaya asset transfers in a dispute involving Skillz subsidiary Firy, according to the headline.
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
U.S. Bankruptcy Court Orders Papaya to Stop Moving Assets Outside the United States
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
US Judge Dismisses Trump Administration’s Harvard Admissions Probe Case
A US judge dismissed the Trump administration’s case concerning its probe of Harvard admissions.
M impact | REGULATION | Nov 02, 2026, 07:12 PM UTC
Judge Dismisses Case Against Former FBI Officials
A judge dismissed the case against former FBI officials and said the Justice Department rushed the charges before the midterms.
L impact | REGULATION | Nov 02, 2026, 05:38 PM UTC
China launches measures to support struggling capital markets
M impact | REGULATION | Nov 02, 2026, 05:26 PM UTC